National and Kapodistrian University of Athens
Μελέτη της ρινικής κάνουλας υψηλής ροής (nasal cannula high flow) έναντι της συμβατικής οξυγονοθεραπείας σε καρδιοχειρουργημένους ασθενείς
Abstract
dc:descriptionIntroduction. Respiratory complications are quite common on cardiac surgical patients postoperatively (3%-89%). The most common risk factors leading to these complications are cardiopulmonary bypass time, older age, heart failure, lung disease, intraoperative maneuvers during harvesting internal mammary artery, potential phrenic nerve damage. Until recently hypoxemic respiratory failure on cardiac surgical patients was treated with conventional oxygen therapy (i.e. low flow and high flow devices, nasal cannula and Venturi mask respectively). It has already been established in research conducted on the recent period that the use of Nasal Cannula High Flow Oxygenation can achieve a) positive airway pressure during expiration b) reduction of dead anatomical air space which leads to improved alveolar ventilation c) reduced air entrainment of supplied oxygen and therefore improved and more stable FiO2 levels d) improved mucociliary function., preservation of tracheobronchial mucosa, and elimination of secretions. Method. A prospective, non-blinded, randomized controlled trial was conducted on cardiac surgical patients who underwent open heart operation on a large tertiary hospital in Athens. The primary target of this study was to evaluate the success of HFNCO vs conventional oxygen therapy treatment on these patients post extubation in the ICU. The secondary target was the comparison of initial HFNCO settings at 60l/min vs initial HFNCO settings at 40l/min regarding respiratory and hemodynamic parameters during ICU stay. Study population included 99 patients on 3 groups of 33 at each group. Study group 1 included patients on FiO2=60%, airflow=60L/min, Study group 2 included patients on FiO2=60%, airflow=40L/min and Control group included patients on Venturi mask, FiO2=60%, 15L/min. Results. Treatment failure was recorded on 4/33 (12.1%), 10/33 (30.3%) and 18/33 (54.5%) of patients on Study group 1, 2 and Control group respectively. Regarding secondary target, there was recorded that patients had significantly higher probability for SpO2>92%, respiration rate within normal range (12-20 breaths/min) and significantly higher number of follow-up time-points for these parameters on Study group 1 vs Study group 2 and Control group respectively. Conclusions. HFNCO seems to present better results as compared to conventional oxygen therapy due to its reduced need for treatment escalation which leads to a faster weaning from increased levels of FiO2. However, more studies on a polycentric scale are needed with larger population samples in order to extract safer and more stable permanent conclusions regarding superiority of HFNCO over conventional oxygen treatment on hypoxemic cardiac surgical patients
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2021
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Theologou, Stavros
- Θεολόγου, Σταύρος
Subjects
dc:subject × 18- Ρινική Κάνουλα
- Οξυγόνωσης
- Υψηλής Ροής
- Καρδιοχειρουργική επέμβαση
- Αποτυχία Θεραπείας
- Αναπνευστική συχνότητα
- Nasal Cannula
- High Flow
- Oxygenation
- Cardiac surgery
- Treatment Failure
- Respiratory rate
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Ιατρική αυξημένης φροντίδας και Εντατική θεραπεία
- Clinical Medicine
- Medical and Health Sciences
- Critical Care and Intensive Care Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/49805